-The Times of India NEW DELHI: Eliminating Planning Commission's role in etching the poverty line and instead tasking expert government agencies to determine India's below poverty line population may help depoliticize the exercise, a former top NSSO official has said. Former director-general of National Sample Survey Organization (NSSO) Jogeshwar Dash feels the Planning Commission's mandate of framing policy clashes with estimating poverty ratios that are an outcome of strategies the panel devises. "Poverty...

-The Hindu Making the Gross Domestic Product the sole measure of national development for many years has left Indians with a natural environment that is among the most polluted in the world. Regardless of that dismal outcome, and in spite of settled law that polluters should pay, the Centre and State governments continue to balk at stronger enforcement of environmental laws. New evidence from a study by the Tata Institute of...

-The Hindu Notional poverty line will stand at a per capita expenditure of around Rs. 50 per day in rural areas and Rs. 62 in urban areas While the Opposition pillories the Planning Commission for using a formal definition of poverty that ensures the percentage of people below the poverty line is lower than what it ought to be, the government has begun moving to a broader and more realistic de facto...

-The Business Standard Nobel Prize-winning economist Amartya Sen, who has just written An Uncertain Glory: India and its Contradictions with Jean Dreze, tells Mihir S Sharma that he doesn't understand why his book has received an angry reaction, or why he is being called anti-growth and pro-redistribution. * Is it startling to discover that you are being called a licence Raj socialist? It is very strange indeed. Perhaps some of this reaction is...

-The Hindu That the Union Health Ministry takes critical decisions affecting a large number of people without any scientific basis does not portend well for public health in India. Neither the ban imposed on the oral anti-diabetes drug pioglitazone on June 18 nor its revocation a month later with a requirement that the medicine be sold with a boxed warning highlighting the adverse side-effect of bladder cancer was based on any...